ALEXANDRA ROJAS: Open Payments
NPI 1699483271 · FREMONT, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 35 payments from 12 companies in 2025. Trend: 2023 $290 · 2024 $882 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $145 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| GlaxoSmithKline, LLC. | 3 | $61 |
| Exact Sciences Corporation | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| PFIZER INC. | 2 | $30 |
| Dexcom, Inc. | 1 | $26 |
| Corcept Therapeutics | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: VRAYLAR, Cologuard Collection Kit, VOQUEZNA, BREZTRI, QULIPTA, TRELEGY ELLIPTA, FARXIGA, SHINGRIX.
Industry payments across OH — which companies pay providers there.
